What is OrbusNeich?
Founded in 2000 and headquartered in Hong Kong, OrbusNeich is a distinguished pioneer in the development and provision of life-changing vascular solutions. The company boasts an extensive portfolio of products that consistently set industry benchmarks in vascular intervention. Its commitment to innovation and quality has positioned it as a key player in the global medical device market, particularly within the specialized field of cardiovascular health.
How much funding has OrbusNeich raised?
OrbusNeich has raised a total of $200M across 1 funding round:
Unspecified
$200M
Unspecified (2021): $200M with participation from Shenzhen Capital Group, CCB International, and China International Capital
Key Investors in OrbusNeich
Shenzhen Capital Group
Shenzhen Capital Group is a prominent venture capital firm known for its investments in technology and innovation across various sectors. Its participation suggests a strategic alignment with OrbusNeich's technological advancements and market potential.
CCB International
CCB International (Holdings) Limited is a comprehensive investment services company owned by China Construction Bank Corporation, offering a wide range of financial products and services including direct investment and asset management, indicating a focus on supporting established companies with significant growth potential.
China International Capital
China International Capital Corporation (CICC) is a leading investment bank providing a full suite of financial services, including investment banking and direct investment. Its involvement points to OrbusNeich's strategic importance and potential for significant financial market impact.
What's next for OrbusNeich?
The substantial enterprise-level funding and recent strategic investment signal a strong confidence in OrbusNeich's future trajectory. This capital is likely to be deployed towards further research and development of novel vascular technologies, expansion into new geographical markets, and potential strategic acquisitions. The company's focus on high-impact vascular solutions suggests a continued emphasis on addressing critical unmet needs in cardiovascular care, positioning it for sustained growth and market leadership.
See full OrbusNeich company page
